Uni-Bio Science Group Announces 2023 Annual Results
Record-breaking Revenue of HK$4 84.7 M and Net Profit of HK$ 70.9 M Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets HONG KONG SAR - EQS Newswire - 27 March 2024 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to ann
read full article
